On behalf of theFogarty International Centerat the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcementsmay be of interest to those working in the field of global health research. Updates are typically distributed once a week. Special Announcements Just announced Fogarty funding opportunities Upcoming Deadlines for Fogarty Funding Opportunities Upcoming deadlines for funding opportunities in which Fogarty is a funding partner Funding Opportunities NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply. - Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)(PAR-22-189)
Application Receipt Date(s): Multiple dates, see announcement. - Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)(PAR-22-192)
Application Receipt Date(s): Multiple dates, see announcement. - Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)(PAR-22-193)
Application Receipt Date(s): Multiple dates, see announcement. - NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)(PAR-22-216)
Application Receipt Date(s): Multiple dates, see announcement. - More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional)(RFA-AG-23-021)
Application Receipt Date(s): October 20, 2022 - BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed)(RFA-EB-22-001)
Application Receipt Date(s): Multiple dates, see announcement. - Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)(RFA-DK-22-021)
Application Receipt Date(s): Multiple dates, see announcement. - Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed)(RFA-MH-22-280)
Application Receipt Date(s): December 5, 2022 - Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed)(RFA-MH-22-281)
Application Receipt Date(s): December 5, 2022 - Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed)(RFA-DK-21-031)
Application Receipt Date(s): October 26, 2022
NIH funding opportunities for which foreign components may apply: - HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)(PAS-22-206)
Application Receipt Date(s): Multiple dates, see announcement. - HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)(PAS-22-207)
Application Receipt Date(s): Multiple dates, see announcement. - HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)(RFA-AT-23-001)
Application Receipt Date(s): November 21, 2022 - HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required)(RFA-AT-23-002)
Application Receipt Date(s): November 21, 2022 - HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required)(RFA-DA-23-041)
Application Receipt Date(s): September 27, 2022 - HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional)(RFA-DA-23-042)
Application Receipt Date(s): September 27, 2022 - HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)(RFA-DA-23-051)
Application Receipt Date(s): February 2, 2023 - Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed)(RFA-DK-22-009)
Application Receipt Date(s): October 26, 2022 - Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)(RFA-DK-22-016)
Application Receipt Date(s): December 20, 2022
Other Funding News General NIH notices that may be of interest to global health researchers: Notices of intent to publish funding opportunities that may be of interest to global health researchers: NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers: Non-NIH funding opportunities that may be of interest to global health researchers: - The American Society of Tropical Medicine and Hygiene (ASTMH) is seeking applications for the Robert E. Shope International Fellowship, which provides $25,000 in support for international training opportunities in arbovirology and emerging diseases for those with an MD, DVM, PhD or the equivalent.
Application deadline: July 29, 2022 - The CRDF Global is accepting proposals from joint U.S., Japan, and other Regional Asia-Pacific (APac)based investigators working in the field of infectious disease and immunology research for The U.S. - Japan Cooperative Medical Sciences Program Collaborative Awards, 2022.
Application Deadline: July 30, 2022 - The Childrens Prizeis awarded to scientifically-minded individuals with a passion for global child health and a strong commitment to verify the impact of their work. Round 1 applications now being accepted.
Application Deadline: July 31, 2022 Featured News and Information Fogarty News NIH News Training Opportunities - The Global Alliance for Chronic Diseases (GACD) Implementation Science Schoolallows early- and mid-career researchers to build their knowledge, skills, and confidence in the fields of implementation science and non-communicable diseases in low- and middle-income countries.
Application deadline: July 25, 2022 - Postdoctoral positions at the National Institute of Allergy and Infectious Diseases (NIAID) are now open in the Virus Ecology Unit within the Laboratory of Virology:
Abstract Submission Opportunities - Catalysing Global Health Innovations for Sustainable Development, a conference hosted by Stellenbosch University (SU) and The Consortium of Universities for Global Health (CUGH), is accepting abstracts for papers, panels, and posted.
Conference dates: October 22-25, 2022 Submissions deadline: August 4, 2022 - CUGH 2023, Global Health at a Crossroads: Equity, Climate Change & Microbial Threatsis accepting abstract and panel submissions.
Conference dates: April 14-16, 2023 Submissions due: September 30, 2022
Events Events for global health researchers: |